Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Synlico announced it raised $3 Million in an initial filing from an offering of $3 Million
PRIVATEFeb 25, 2025•over 1 year ago
Amount Raised
$3 Million
Round Type
Seed
South San FranciscoOther
Company Information
Company
Synlico
Location
329 Oyster Point Blvd Fl 3
South San Francisco, California, United States
About
Synlico Inc. is on a vision to rewrite biology and medicine with data-driven computing. As a biotechnology company, we focus our mission on developing cutting-edge T cell therapies for the treatment of solid tumors. By using the latest advancements in system biology, single-cell bioinformatics, and synthetic biology, the team at Synlico is creating a computational platform that will change the way we discover and design drugs. This platform is designed to tackle the complexity and heterogeneity of the tumor micro-environment, allowing Synlico to engineer T cells that specifically target each patient's unique needs. With a strong focus on innovation, Synlico is positioned to succeed in developing targeted treatments tailored to each patient.
Don't miss Synlico's next move
Get an email the moment Synlico raises, hires an exec, or expands, usually minutes after it happens.